In vivo activities of evernimicin (SCH 27899) against vancomycin-susceptible and vancomycin-resistant enterococci in experimental endocarditis.

Abstract

To assess the potential efficacy of evernimicin (SCH 27899) against serious enterococcal infections, we used a rat model of aortic valve endocarditis established with either a vancomycin-susceptible Enterococcus faecalis or a vancomycin-resistant Enterococcus faecium strain. Animals infected with either one of the test strains were assigned to receive no… (More)

Topics

Cite this paper

@article{Souli2000InVA, title={In vivo activities of evernimicin (SCH 27899) against vancomycin-susceptible and vancomycin-resistant enterococci in experimental endocarditis.}, author={Mhamed Souli and Claudie Thauvin-Eliopoulos and George M. Eliopoulos}, journal={Antimicrobial agents and chemotherapy}, year={2000}, volume={44 10}, pages={2733-9} }